v2.3.0.11
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands
 3 Months Ended
Jun. 30, 2011
Jul. 01, 2010
Cash flows from operating activities:    
Net earnings $ 285 $ 9,612
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 51,818 48,603
Theatre and other closure expense 2,544 196
Equity in earnings and losses from non-consolidated entities, net of distributions 1,753 3,686
Gain on dispositions   (10,056)
Change in assets and liabilities, net of acquisitions:    
Receivables (17,044) (14,232)
Other assets (5,274) (1,147)
Accounts payable 41,206 8,199
Accrued expenses and other liabilities 1,150 (8,264)
Other, net (1,111) (1,298)
Net cash provided by operating activities 75,327 35,299
Cash flows from investing activities:    
Capital expenditures (32,018) (13,988)
Acquisition of Kerasotes, net of cash acquired   (276,798)
Proceeds from sale/leaseback of digital projection equipment 953  
Proceeds from disposition of Cinemex   876
Investments in non-consolidated entities, net (19,509) 43
Proceeds from the disposition of long-term assets   55,000
Other, net (1,180) (28)
Net cash used in investing activities (51,754) (234,895)
Cash flows from financing activities:    
Deferred financing costs (231) (95)
Principal payments under capital and financing lease obligations (1,050) (990)
Principal payments under Term Loan (1,625) (1,625)
Change in construction payables (6,913) (7,737)
Net cash used in financing activities (9,819) (10,447)
Effect of exchange rate changes on cash and equivalents (287) 402
Net increase (decrease) in cash and equivalents 13,467 (209,641)
Cash and equivalents at beginning of period 301,158 495,343
Cash and equivalents at end of period $ 314,625 $ 285,702